Search Thermo Fisher Scientific
Five respiratory viruses. One TaqPath panel.
Expand your molecular testing menu with the TaqPath Respiratory Viral Select Panel.
The Applied Biosystems TaqPath Respiratory Viral Select Panel is a multiplex, real-time PCR (qPCR) in vitro diagnostic (IVD) test for identifying five common respiratory viruses in under three hours. The CE-IVD panel includes targets for adenovirus, human metapneumovirus, rhinovirus/enterovirus,* and parainfluenza** virus. Pair this panel with the Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit to expand your respiratory virus testing menu.
* Rhinovirus/enterovirus are undifferentiated.
** Coverage of parainfluenza virus includes subtypes 1, 2, 3, and 4; undifferentiated.
Shared symptoms, different viruses
Whether we are experiencing a seasonal surge or a global pandemic, early and accurate diagnosis of respiratory infections can save lives. As more viral pathogens enter the ecosystem, multiplex testing helps provide the accuracy needed to test for multiple viruses with overlapping infection symptoms.
As demand for reliable respiratory testing solutions continues to grow, we can help you catch up to surges in testing. Our robust multiplex assays, combined with high-quality PCR systems, are designed to enable the detection of five respiratory viruses using the same patient sample.
Get your pathogens straight!
Download this free educational poster on respiratory tract infections.
Offering high sensitivity and fast time-to-results, this powerful PCR panel makes it easy and affordable for you to adopt and add targets to your respiratory testing menu. As the technological migration from rapid to molecular testing continues, the need for expanded molecular testing remains beneficial for at-risk populations, including children, older adults, and people with weakened immune systems. These populations are often at higher risk of severe disease and hospitalization, and need clear answers. PCR testing is designed to deliver accurate results and aid in differential diagnosis, including coinfections, to assist with treatment or other patient management decisions.
Learn more by reading the article, The rise of qPCR testing in clinical diagnostics. Read now ›
Select Taqpath panels
Validated workflow
Its full workflow, from sample preparation to software-generated result in just 3 hours, makes it easy to implement
Single tube
Detecting 5 viruses and an endogenous internal control, all in a single well, makes it easy to perform routine patient testing
Affordable price
Easily adopt this panel, and never overpay for the targets you need
PCR performance
High sensitivity for the vast majority of strains gives you confidence in results
Controls included
Included RNase P and positive controls offer reliable runs, time after time
Flexible throughput
Scalable to fit your needs, allowing you to test from 1 to 94 samples, as needed
Choose Thermo Fisher Scientific
In a time when getting answers quickly is critical, Thermo Fisher Scientific—a global leader in COVID-19 testing—is leveraging its scale and resources to help the world move forward. With innovative solutions and a reliable supply chain already helping to meet the unprecedented demand for trusted COVID-19 testing, we are continuing to expand our high-quality solutions and urgently accelerate innovation to address current and future challenges.
Trusted technology
Our validated workflow includes the Thermo Scientific KingFisher Flex Purification System for nucleic acid extraction and Applied Biosystems QuantStudio 5 or 5 Dx real-time PCR systems.
Service and support
Rely on one company for service and support of all steps of the validated workflow. Our experts will help you get up and running and maintain your growing molecular menu.
Growing menu
Our expanding portfolio of Applied Biosystems CE-IVD panels allows you to get more from your existing equipment, like the new Applied Biosystems TaqPath Enteric Bacterial Select Panel.
Access pricing available to eligible customers. Contact us to learn more.
Product details
Targets |
|
Internal control | RNase P |
Positive control | Included |
Authorized sample types | Nasopharyngeal (NP) swab |
Authorized sample prep |
|
Authorized kit | TaqPath Respiratory Viral Select Panel |
Authorized real-time PCR systems |
|
Sample-to-result turnaround time | ~3 hours |
Software | Pathogen Interpretive Software CE-IVD Edition |
Approval | CE-IVD |
Add to your diagnostic testing capabilities using the PCR experience you already have. The fully validated TaqPath Respiratory Viral Select Panel detects common respiratory viruses that share overlapping symptoms, including adenovirus, human metapneumovirus, rhinovirus/enterovirus, and parainfluenza virus.
The TaqPath Respiratory Viral Select Panel assay has been validated for use with nasopharyngeal (NP) swabs obtained from individuals exhibiting symptoms of a respiratory tract infection.
Featured resources
Five respiratory viruses. One TaqPath panel.
The new, fully validated TaqPath Respiratory Viral Select Panel is a multiplex, real-time PCR (qPCR) in vitro diagnostic (IVD) test for identifying five common respiratory viruses in under three hours.
Blog: The need to expand your molecular respiratory testing
While COVID-19 testing is a top priority for many countries around the world, it is a good time to use those lessons learned and apply them to the viruses causing the common cold.
Article: The rise of qPCR testing in clinical diagnostics
On this sponsored piece, we hear what industry experts believe is the future of molecular testing after lessons of the COVID-19 pandemic.
Analysis and reporting
The Applied Biosystems Pathogen Interpretive Software (CE-IVD) is part of the required workflow and must be downloaded prior to instrumentation use. You may download the software upon kit purchase. Labs following the authorized workflow are required to complete an eLearning course and pass an exam to download.
Follow the instructions below to obtain the software from your local support team:
- Go to thermofisher.com/contactus
- Select “Instrument Service” as category
- Enter product name or Cat. No. and select your country
- Call the local number displayed on the screen
Interested in this product?
Solution for COVID-19, Flu A/B, and RSV
Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This CE-IVD marked multiplex PCR test is specifically designed to detect and differentiate between multiple respiratory viruses as the ongoing COVID-19 pandemic overlaps with respiratory virus season.
Ordering information
| Catalog # | Name | Size | Price (GBP) | Qty |
|---|---|---|---|---|
| A54713 | TaqPath ™ Respiratory Viral Select Panel | 200 reactions | Order now | - |
For In Vitro Diagnostic Use. © 2022 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.
Style Sheet for Global Design System